Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815) |
---|
09/26/2001 | EP1135380A1 Process for the preparation of simvastatin and analogs thereof |
09/26/2001 | EP0833825B1 6-carboxamido dihydropyran derivatives |
09/26/2001 | EP0725778B1 Recombinant production of novel polyketides |
09/25/2001 | US6294680 Process for the production of semi synthetic statins via novel intermediates |
09/25/2001 | US6294572 Crystalline N-acetyl neuraminic acid derivatives and process for their preparation |
09/20/2001 | WO2001068633A1 2-phenylpyran-4-one derivatives |
09/20/2001 | WO2001068582A1 Novel fatty acid analogous |
09/20/2001 | WO2001068575A1 Fluoroalkylonium salt type cation or acid generator generating cation or acid upon irradiation with energy ray |
09/20/2001 | WO2001068084A1 Il-8 receptor antagonists |
09/20/2001 | CA2403149A1 2-phenylpyran-4-one derivatives |
09/20/2001 | CA2403062A1 Il-8 receptor antagonists |
09/19/2001 | EP1133699A1 Prevention and treatment of amyloid-associated disorders |
09/19/2001 | EP0989909B1 Catalyst obtained from phosphinoalkyl-functionalized polystyrene and method for the production of delta-lactone |
09/19/2001 | CN1313846A C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cystenine proteases |
09/18/2001 | US6291390 Catalyst obtained from phosphinoalkyl-functionalized polystyrene and method for the production of δ-lactone |
09/13/2001 | WO2001066538A1 A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities |
09/13/2001 | WO2001066537A1 Novel substance fki-0076 and process for producing the same |
09/13/2001 | CA2402061A1 A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities |
09/12/2001 | EP1131311A1 2-acylamino-2-deoxy-glucono-1,5-lactones, method for obtaining same, compositions comprising them and uses |
09/12/2001 | EP1131060A2 Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an hmg coa reductase inhibitor |
09/11/2001 | US6288246 Reaction of hydroxylamine with alkylsilyl halide, hydrolysis with acid |
09/11/2001 | US6288109 Pyranones, method for the production and use thereof |
09/11/2001 | US6288102 Substituted phenylketoenols and their use as pesticides and herbicides |
09/11/2001 | US6288086 N-hydroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
09/11/2001 | US6288068 Administering 1,4-disubstited piperidine derivative; alzheimer*s disease, cognition activators; anticholinergic agents |
09/11/2001 | CA2018824C Use of kojic acid for treating pigmentation diseases |
09/07/2001 | WO2001064663A2 Biologically active analogs of discodermolide |
09/06/2001 | US20010020021 Metalloprotease inhibitor |
09/06/2001 | US20010019837 Process for microbially oxidizing n-substituted glucamines |
09/05/2001 | EP1129086A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
09/05/2001 | CN1070487C Hexahydronaphthalene ester derivatives, their prepn. and their therapeutic uses |
09/04/2001 | USH1992 Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their pharmaceutical uses |
08/30/2001 | WO2001062949A1 Method of purifying a fermentation broth |
08/30/2001 | US20010018446 Atherosclerosis, dyslipemia |
08/30/2001 | CA2400952A1 Method of purifying a fermentation broth |
08/29/2001 | EP1127886A1 Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-2H-pyran-2one |
08/29/2001 | EP1127055A2 Stereoselective process for producing cryptophycins |
08/29/2001 | CN1310704A Hydroxamic acid derivatives and medicinal utilization thereof |
08/29/2001 | CN1310629A Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions |
08/29/2001 | CN1070189C Fluoromethoxyacrylic acid derivatives |
08/28/2001 | US6281365 (Gem-heterocyclodimethanamine-n,n′)platinum complexes |
08/28/2001 | US6280859 Light-emitting material for organo-electroluminescence device and for organic electroluminescence device which the material is applied |
08/22/2001 | EP1124828A1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
08/22/2001 | EP1124813A1 Microbial transformation product |
08/22/2001 | EP1124443A1 Solid delivery systems for aroma ingredients |
08/22/2001 | EP0785926B1 Carboxylic acid derivatives, their preparation and their use as medicaments |
08/22/2001 | CN1309634A Hydrazine derivs. |
08/21/2001 | US6278001 Method for preparing (+) compactin and (+) mevinolin analog compounds having a β-hydroxy-δ-lactone grouping |
08/21/2001 | US6277885 Inhibitors of tumor necrosis factor-alpha converting enzyme |
08/21/2001 | CA2070697C Octalactone-containing composition, fermentation process for producing same and organoleptic uses thereof |
08/21/2001 | CA2026143C Triazole compounds, their production and use |
08/16/2001 | US20010014688 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
08/16/2001 | EP1123272A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
08/16/2001 | EP0877742B1 Method of production of lovastatin |
08/16/2001 | EP0759916B1 Explosive compositions |
08/14/2001 | US6274745 Binaphthol monophosphoric acid derivative and its use |
08/14/2001 | US6274736 Chromatographic enantiomer separation of lactones |
08/14/2001 | US6274560 Incubating diketide with modified polyketide synthase; recovering; genetic engineering |
08/14/2001 | US6274360 Conversion of compactin to pravastatin by Actinomadura |
08/09/2001 | WO2001057014A2 Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one |
08/08/2001 | CN1307583A Method for preparing aloin by extraction |
08/07/2001 | US6271398 Process for producing simvastatin and/or its derivatives |
08/07/2001 | US6271194 Perfume |
08/07/2001 | US6271180 Substituted phenyl keto enols as pesticides and herbicides |
08/02/2001 | WO2001055101A2 A new process for the preparation of latanoprost |
08/02/2001 | WO2001055097A1 Preparation of nitrogen mustard derivatives |
08/02/2001 | WO2001054501A2 Herbicidal composition |
08/02/2001 | CA2398304A1 A new process for the preparation of latanoprost |
08/01/2001 | EP1119559A1 3-phenyl-pyrones |
08/01/2001 | CN1305993A Cyclic guanyl preparation used as nitrogen oxide synthetic enzyme inhibitor |
07/31/2001 | US6268357 Organic vanadium (III) complexes and their use |
07/31/2001 | US6268354 Pharmaceutical composition for antagonizing CCR5 comprising anilide derivative |
07/31/2001 | US6268186 By recovering compounds such as lovastatin from a fermentation broth by purifying with an adsorbent resin, extraction using toluene, lactonization, if necessary and washing in toluene with water before isolation |
07/26/2001 | US20010009964 Catalyst for preparing lactone and a method for preparing lactone |
07/25/2001 | EP1118665A1 Recombinant production of aromatic polyketides |
07/25/2001 | EP1117639A1 Benzoylcyclohexandiones, method for the production and use thereof as herbicides and plant growth regulators |
07/25/2001 | EP0885391A4 Method of detection of influenza virus and compounds for use therein |
07/25/2001 | CN1305447A Optically active compounds |
07/25/2001 | CN1304921A Method of using easy removed nitroxyl selective alcohol axide |
07/24/2001 | US6265604 (R)-3-hydroxy-3-(2-phenylethyl)-hexanoic acid derivatives |
07/19/2001 | WO2001051481A1 Method for the synthesis of 6n-pentyl-2h-pyran-2-one |
07/19/2001 | WO2001051480A1 Agents correcting gene expression regulatory error |
07/19/2001 | WO2001051058A1 Use of a cyclic ether for the preparation of medicaments affecting glucose tolerance |
07/19/2001 | WO2001005758A3 Indoles and indazoles for the treatment of migraine |
07/19/2001 | WO2001005392A3 Method for treating chronic pain using mek inhibitors |
07/19/2001 | CA2383158A1 Use of a cyclic ether for the preparation of medicaments affecting glucose tolerance |
07/18/2001 | EP1115716A1 2-phenylpyran-4-one derivatives |
07/18/2001 | EP1115695A1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |
07/18/2001 | EP1115694A1 Substituted n-aliphatic-n-aromatic (tertiary)-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
07/18/2001 | EP1115693A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
07/18/2001 | EP0636025B1 Compounds useful for treating allergic or inflammatory diseases |
07/17/2001 | US6261826 Antibiotic TKR2648 and process for producing the same |
07/11/2001 | EP1114040A1 PROCESS FOR OBTAINING HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY |
07/11/2001 | EP1114021A1 NEW SALTS OF HMG-CoA REDUCTASE INHIBITORS |
07/11/2001 | CN1303375A Aryl phenyl substituted cyclic ketoenols |
07/11/2001 | CN1068322C Process for preparing heterocyclic aldehydes |
07/05/2001 | WO2001047910A1 Process for preparation of tetrahydropyranyloxyamines |
07/04/2001 | EP1112269A2 Hiv protease inhibitors |
07/04/2001 | EP1112262A1 SUBSTITUTED $g(g)-PHENYL-$g(D)-LACTONES AND ANALOGS THEREOF AND USES RELATED THERETO |
07/04/2001 | EP1112240A1 The addition of oxygen nucleophiles to vinyl epoxides |